NYSE: DVA
Davita Inc Stock

$140.95+4.61 (+3.38%)
Updated Jun 24, 2025
DVA Price
$140.95
Fair Value Price
N/A
Market Cap
$10.64B
52 Week Low
$131.76
52 Week High
$179.60
P/E
13.64x
P/B
-39.84x
P/S
0.94x
PEG
1.33x
Dividend Yield
N/A
Revenue
$12.97B
Earnings
$859.61M
Gross Margin
32.5%
Operating Margin
12.6%
Profit Margin
6.6%
Debt to Equity
-57.88
Operating Cash Flow
$2B
Beta
0.57
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A

DVA Overview

DaVita Inc. provides kidney dialysis services through a network of outpatient dialysis centers in the U.S and internationally. The company primarily treats end-stage renal disease, which requires patients to undergo dialysis 3 times per week for the rest of their lives unless they receive a donor kidney. Seventy percent of the company's revenues come from Medicare and other government-based health insurance programs. The company was founded in 1979 and is based in Denver, CO.

Zen Rating

Our proven quant model uses 115 proprietary factors, including AI, to determine DVA's potential to beat the market

CHold
  • Stocks with a Zen Rating of Hold (C) had an average return of +7.53% per year. Learn More

Zen Rating Component Grades

C
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.

Industry: Medical Care Facility

Industry Rating
B
DVA
Ranked
#21 of 42

Top Ranked Stocks in Industry

View Top Medical Care Facility Stocks

Be the first to know about important DVA news, forecast changes, insider trades & much more!

DVA News

Overview

Due Diligence Score

Industry Average (29)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how DVA scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

DVA ($140.95) is trading above its intrinsic value of $94.46, according to an updated version of Benjamin Graham's Formula from Chapter 11 of "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
DVA is good value based on its earnings relative to its share price (13.64x), compared to the US market average (32.13x)
P/E vs Market Valuation
DVA is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
There are 30 more DVA due diligence checks available for Premium users.

Valuation

DVA price to earnings (PE)

For valuing profitable companies with steady earnings

Company
13.64x
Industry
16.71x
Market
32.13x
DVA is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
DVA is good value based... subscribe to Premium to read more.
P/E vs Market Valuation

DVA price to book (PB)

For valuing companies that are loss-making or have lots of physical asset

Company
-39.84x
Industry
4.62x

DVA price to earnings growth (PEG)

For valuing profitable companies with growth potential

DVA is poor value relative... subscribe to Premium to read more.
PEG Value Valuation

DVA's financial health

Profit margin

Revenue
$3.2B
Net Income
$162.9M
Profit Margin
5.1%
DVA's Earnings (EBIT) of $1.63B... subscribe to Premium to read more.
Interest Coverage Financials
DVA's profit margin (6.6%) has... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$17.1B
Liabilities
$15.5B
Debt to equity
-57.88
DVA's short-term assets ($3.64B) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
DVA's long-term liabilities ($12.55B) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
DVA's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
DVA's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
$180.0M
Investing
-$162.1M
Financing
-$382.5M
DVA's operating cash flow ($2.34B)... subscribe to Premium to read more.
Debt Coverage Financials

DVA vs Medical Care Facility Stocks

TickerZen RatingMarket Cap1d %P/EP/B
DVAC$10.64B+3.38%13.64x-39.84x
UHSB$11.29B+0.97%9.66x1.66x
EHCB$12.19B+0.58%24.63x5.65x
ENSGC$8.83B+0.92%28.18x4.58x
CHEB$8.15B+1.04%26.91x6.90x

Davita Stock FAQ

What is Davita's quote symbol?

(NYSE: DVA) Davita trades on the NYSE under the ticker symbol DVA. Davita stock quotes can also be displayed as NYSE: DVA.

If you're new to stock investing, here's how to buy Davita stock.

What is the 52 week high and low for Davita (NYSE: DVA)?

(NYSE: DVA) Davita's 52-week high was $179.60, and its 52-week low was $131.76. It is currently -21.52% from its 52-week high and 6.97% from its 52-week low.

How much is Davita stock worth today?

(NYSE: DVA) Davita currently has 75,500,000 outstanding shares. With Davita stock trading at $140.95 per share, the total value of Davita stock (market capitalization) is $10.64B.

Davita stock was originally listed at a price of $9.17 in Dec 31, 1997. If you had invested in Davita stock at $9.17, your return over the last 27 years would have been 1,437.58%, for an annualized return of 10.65% (not including any dividends or dividend reinvestments).

How much is Davita's stock price per share?

(NYSE: DVA) Davita stock price per share is $140.95 today (as of Jun 24, 2025).

What is Davita's Market Cap?

(NYSE: DVA) Davita's market cap is $10.64B, as of Jun 25, 2025.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Davita's market cap is calculated by multiplying DVA's current stock price of $140.95 by DVA's total outstanding shares of 75,500,000.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.